mar 8, 2024 - Wegovy Approved by The FDA
Description:
The FDA expands the approval of semaglutide (Wegovy) to include heart disease, making it the first weight-loss drug to be approved for reducing the risk of cardiovascular events in adults who have cardiovascular disease and are either obese or overweight.
Added to timeline:
Date:
~ 1 years and 3 months ago